Illinois 2023-2024 Regular Session

Illinois Senate Bill SR0136 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1	SR0136LRB103 31458 MST 59199 r SR0136 LRB103 31458 MST 59199 r
2	2	SR0136 LRB103 31458 MST 59199 r
3	3	1 SENATE RESOLUTION
4	4	2 WHEREAS, Respiratory Syncytial Virus disease (RSV) is a
5	5	3 highly transmissible, seasonal virus that can have severe and
6	6	4 unpredictable outcomes for infants, including hospitalization;
7	7	5 and
8	8	6 WHEREAS, Nearly all children will be infected with RSV by
9	9	7 age two, and most infants requiring hospitalization were
10	10	8 previously healthy and born at term; and
11	11	9 WHEREAS, RSV is the leading cause of hospitalization among
12	12	10 infants in the U.S.; and
13	13	11 WHEREAS, RSV is the most common cause of bronchiolitis
14	14	12 (inflammation of the small airways in the lung) and pneumonia
15	15	13 (infection of the lungs) in children younger than one year of
16	16	14 age in the U.S.; and
17	17	15 WHEREAS, The current RSV season has resulted in
18	18	16 significant morbidity and increased mortality; and
19	19	17 WHEREAS, In the U.S., RSV infections typically occur
20	20	18 during late fall, winter, and early spring, which means urgent
21	21	19 preparation is needed; and
22	22
23	23
24	24
25	25	SR0136 LRB103 31458 MST 59199 r
26	26
27	27
28	28	SR0136- 2 -LRB103 31458 MST 59199 r SR0136 - 2 - LRB103 31458 MST 59199 r
29	29	SR0136 - 2 - LRB103 31458 MST 59199 r
30	30	1 WHEREAS, Monoclonal antibodies show promise in
31	31	2 preventative protection against RSV; and
32	32	3 WHEREAS, RSV disproportionally affects infants with
33	33	4 Medicaid coverage, Native Americans, and Alaskan Natives; and
34	34	5 WHEREAS, The Vaccines For Children (VFC) program is a
35	35	6 federally-funded program that provides vaccines at no cost to
36	36	7 children who might not otherwise be vaccinated because of
37	37	8 inability to pay; and
38	38	9 WHEREAS, VFC coverage is critical to ensure equity and
39	39	10 access for all infants in order to have the greatest impact on
40	40	11 disease burden; therefore, be it
41	41	12 RESOLVED, BY THE SENATE OF THE ONE HUNDRED THIRD GENERAL
42	42	13 ASSEMBLY OF THE STATE OF ILLINOIS, that we urge the Centers for
43	43	14 Disease Control and Prevention to include new RSV immunization
44	44	15 technologies (including vaccines and monoclonal antibodies),
45	45	16 within the federal VFC program if the Advisory Committee on
46	46	17 Immunization Practices of the Centers for Disease Control and
47	47	18 Prevention issues administrative recommendations that are
48	48	19 subsequently approved by the Director of the Centers for
49	49	20 Disease Control and Prevention; and be it further
50	50	21 RESOLVED, That suitable copies of this resolution be
51	51
52	52
53	53
54	54
55	55
56	56	SR0136 - 2 - LRB103 31458 MST 59199 r
57	57
58	58
59	59	SR0136- 3 -LRB103 31458 MST 59199 r SR0136 - 3 - LRB103 31458 MST 59199 r
60	60	SR0136 - 3 - LRB103 31458 MST 59199 r
61	61	1 delivered to Director of the Centers for Disease Control and
62	62	2 Prevention Rochelle Walensky, Administrator of the Centers for
63	63	3 Medicare and Medicaid Services (CMS) Chiquita Brooks-LaSure,
64	64	4 and Secretary of the Department of Health and Human Services
65	65	5 Xavier Becerra.
66	66
67	67
68	68
69	69
70	70
71	71	SR0136 - 3 - LRB103 31458 MST 59199 r